Skip to main content

3 articles related to "Programmed Death Ligand 1 And 2"

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Review

Published on 01 Mar 2018

Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer

in Molecular Innate Immunity

Maarten Versteven
Johan M. J. Van den Bergh
Elly Marcq
Evelien L. J. Smits
Viggo F. I. Van Tendeloo
Willemijn Hobo
Eva Lion

Frontiers in Immunology

doi 10.3389/fimmu.2018.00394

20,141 views
90 citations

Original Research

Published on 11 Aug 2014

Targeting immune co-stimulatory effects of PD-L1 and PD-L2 might represent an effective therapeutic strategy in stroke

in Cellular Neuropathology

Sheetal Bodhankar
Yingxin Chen
Andrew Lapato
Arthur A. Vandenbark
Stephanie J Murphy
HALINA OFFNER

Frontiers in Cellular Neuroscience

doi 10.3389/fncel.2014.00228

8,242 views
13 citations

Original Research

Published on 09 Dec 2016

PD-L1 Is Not Constitutively Expressed on Tasmanian Devil Facial Tumor Cells but Is Strongly Upregulated in Response to IFN-γ and Can Be Expressed in the Tumor Microenvironment

in Cancer Immunity and Immunotherapy

Andrew S. Flies
A. Bruce Lyons
Lynn M. Corcoran
Anthony T. Papenfuss
James M. Murphy
Graeme W. Knowles
Gregory M. Woods
John D. Hayball

Frontiers in Immunology

doi 10.3389/fimmu.2016.00581

11,929 views
45 citations